Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology
用于心脏研究、安全药理学的优化比例电压敏感染料
基本信息
- 批准号:10699121
- 负责人:
- 金额:$ 95.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-08 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsArrhythmiaBasic ScienceBiological AssayBusinessesCardiacCardiac Electrophysiologic TechniquesCardiac MyocytesCardiotoxicityCatalogsCell LineCell membraneCellsChemicalsClinicalCommunitiesConnecticutDevelopmentDrug ScreeningDrug toxicityDyesElectrodesElectrophysiology (science)FluorescenceFluorescent DyesFutureGenerationsGenetic Predisposition to DiseaseGoalsGrowthHeartHeart ResearchHeart failureHumanImageIndividualLegal patentLicensingLightLinkMapsMarketingMeasuresMethodsMorphologic artifactsMotionNeurosciencesNoiseOpticsOrganPatientsPenetrationPerformancePharmaceutical PreparationsPharmacologyPhasePhysiologyPreparationPropertyProteinsReagentRecordsResearchResearch PersonnelResolutionSafetyScientistSignal TransductionSmall Business Innovation Research GrantSourceSpeedStainsTechnologyTestingThickTimeTissuesToxic effectToxicologyUniversitiesWorkcalcium indicatorchromophoreclinical imagingcommercializationdesigndrug actiondrug discoveryexperimental studyheart cellhigh resolution imaginghigh throughput screeninghuman stem cellsimprovedin vivoinduced pluripotent stem cell derived cardiomyocytesinsightinventionlight intensitynovelnovel therapeuticsoptogeneticspersonalized diagnosticspersonalized medicineratiometricrational designresearch and developmentscreeningspatiotemporaltissue/cell culturetoolvoltagevoltage sensitive dyewater solubility
项目摘要
Project Summary/Abstract Potentiometric Probes
The overall goal of this Phase II SBIR project is to commercialize tools, invented by the
founders of Potentiometric Probe, LLC, for high-fidelity optical recording of electrical activity in
cardiac cells, tissues, and whole hearts. Potentiometric Probes develops organic
voltage-sensitive dyes (VSDs) that convert the changes in voltage across cell membranes to
visible changes in fluorescence. Instead of individual electrodes, this technology enables the
use of sensitive high-speed cameras, where each pixel can be considered an electrode, for
massively parallel high throughput screening, or for high-resolution spatiotemporal maps of
electrical signal propagation. Importantly, our VSDs are unique in enabling dual-wavelength
ratiometric recording of electrical activity; this is particularly important for cardiac studies
because it eliminates contraction-induced motion artifacts, permitting high-fidelity records of the
action potential waveform. Human stem cell-derived cardiomyocytes (hiPSC-CMs) and tissues
derived from them are increasingly being used for research and development purposes,
including screening new drugs for cardiotoxicity, and in the future may be used for “personalized
medicine” and the analysis of patient-derived cells. We believe high throughput recording of
accurate action potential waveforms from hiPSC-CMs and tissues will be a major market for the
proposed technology. Ultimately, the technology may also be applied clinically for
high-resolution imaging of action potential propagation in the heart. In this proposal,
Potentiometric Probes will synthesize a set of stable, non-toxic ratiometric VSDs with a broad
selection of spectral windows, allowing accurate recordings even from beating hearts. The
performance of these VSDs will also be fully characterized and validated for their compatibility
with sensitive cell lines for both long-term and high-throughput recordings.
项目摘要/摘要电位探针
第二阶段 SBIR 项目的总体目标是将由
Potentiometric Probe, LLC 的创始人,用于高保真光学记录电活动
心肌细胞、组织和整个心脏发育有机。
电压敏感染料 (VSD) 可将细胞膜上的电压变化转换为
该技术无需使用单独的电极,即可实现荧光的可见变化。
使用灵敏的高速相机,其中每个像素都可以被视为一个电极,
大规模并行高通量筛选,或用于高分辨率时空图
重要的是,我们的 VSD 在实现双波长方面是独一无二的。
电活动的比率记录;这对于心脏研究尤其重要
因为它消除了收缩引起的运动伪影,从而允许高保真度记录
动作电位波形。人类干细胞衍生的心肌细胞 (hiPSC-CM) 和组织。
从它们中提取的物质越来越多地用于研究和开发目的,
包括筛选新药的心脏毒性,未来可能用于“个性化”
我们相信高通量记录。
hiPSC-CM 和组织的准确动作电位波形将是该技术的主要市场
最终,该技术也可以应用于临床。
心脏中动作电位传播的高分辨率成像。
电位探针将合成一组稳定、无毒的比率 VSD,具有广泛的用途
选择光谱窗口,甚至可以准确记录跳动的心脏。
这些 VSD 的性能也将得到全面的表征和兼容性验证
具有用于长期和高通量记录的敏感细胞系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Corey Acker其他文献
Corey Acker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Corey Acker', 18)}}的其他基金
Improved Ratiometric Voltage-Sensitive Dyes for In-Vitro and In-Vivo Imaging of Brain Electrical Signaling
改进的比例电压敏感染料用于脑电信号的体外和体内成像
- 批准号:
10018113 - 财政年份:2019
- 资助金额:
$ 95.85万 - 项目类别:
相似国自然基金
LAMA2调控细胞力学信号致心律失常性心肌病发生的分子机制研究
- 批准号:82370325
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
阻断TRPV4通过抑制线粒体内PDHE1α乙酰化减少心衰后恶性室性心律失常的发生的机制研究
- 批准号:82370329
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
利用心脏类器官模型探讨发热诱发Brugada综合征患者心律失常的机制研究
- 批准号:82300352
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FHF1招募乙酰转移酶p300调控复极储备在心肌肥厚室性心律失常中的作用及机制
- 批准号:82360072
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
β-AR调控再生心肌复极离散度参与hiPSC移植致心律失常作用的机制研究
- 批准号:82370289
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Structural and Pharmacological Study of the KCNQ1/KCNE1 Potassium Channel Complex
KCNQ1/KCNE1 钾通道复合物的结构和药理学研究
- 批准号:
10355435 - 财政年份:2018
- 资助金额:
$ 95.85万 - 项目类别:
Structural and Pharmacological Study of the KCNQ1/KCNE1 Potassium Channel Complex
KCNQ1/KCNE1 钾通道复合物的结构和药理学研究
- 批准号:
10083223 - 财政年份:2018
- 资助金额:
$ 95.85万 - 项目类别:
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy
高通量筛选发现用于心力衰竭治疗的漏性 RyR2 新型抑制剂
- 批准号:
10064096 - 财政年份:2018
- 资助金额:
$ 95.85万 - 项目类别: